Blog

In clinical research, Good Clinical Practice (GCP) sets ethical and quality standards. Non-compliance during audits poses systemic risks to patient

The pharmaceutical industry relies on innovation, but not all companies can fully develop a drug. Strategic licensing, including In-Licensing and

The announcement of a Good Manufacturing Practice (GMP) audit often instills anxiety among pharmaceutical, biotech, or medical device facilities. The

In the competitive landscape of life sciences, the Regulatory Affairs (RA) division has evolved from merely a compliance-related function into

In the dynamic landscape of the pharmaceutical industry, drug discovery represents only the initial phase of a much more complex

In the domain of clinical research, the announcement of a Good Clinical Practice (GCP) audit is often met with apprehension,

In the competitive and highly regulated pharmaceutical industry, the goal of growth introduces complexity in various operational areas, particularly in

For decades, the standard practice in clinical trial monitoring involved a uniform method characterized by 100% Source Data Verification (SDV)

In the fast-paced and highly regulated world of pharmaceuticals, ensuring product safety, efficacy, and quality is non-negotiable. Zenovel relies on

In clinical research, building an effective team is crucial for trial success and timely treatment delivery. Zenovel, a trusted provider

In the pharmaceutical and life sciences sectors, documentation control is critical for ensuring compliance, product quality, and patient safety. Adhering

India’s pharmaceutical industry is poised for significant growth, with projections estimating its market value to reach $130 billion by 2030.

Developing new medications is a complex and costly scientific process that takes 10-15 years and requires billions of dollars to